Analytical Data
-
基因名
vwc2l
- Application
-
别名
vwc2l；von Willebrand factor C domain-containing Protein 2-like
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
B2RUY7
-
表达区间
22-222aa
-
氨基酸序列
AAISHEDYP ADEGDQISSN DNLIFDDYRG KGCVDDSGFV YKLGERFFPG HSNCPCVCAL DGPVCDQPEC PKIHPKCTKV EHNGCCPECK EVKNFCEYHG KNYKILEEFK PSPCEWCRCE PSNEVHCVVA DCAVPECVNP VYEPEQCCPV CKNGPNCFAG TTIIPAGIEV KVDECNICHC HNGDWWKPAQ CSKRECQGKQ TV
-
分子量
24.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human EXOSC8 Protein，His
Cat：PA1000-1062
Recombinant E.coli mutS Protein，His
Cat：PA2000-3815
Recombinant Human EXOSC7 Protein，His
Cat：PA1000-1061
Protein Description
VWC2L, or von Willebrand factor C domain containing 2-like protein, is a member of the von Willebrand factor family, which plays a critical role in various biological processes, including cell adhesion, signaling, and ligation. Its unique structure, characterized by the presence of von Willebrand factor C domains, suggests potential functions in cardiovascular biology and hemostasis. Recent studies have indicated that VWC2L may be involved in the modulation of vascular permeability and inflammation, making it a compelling target for research in cardiovascular diseases and disorders related to coagulation. Recombinant VWC2L proteins have been produced to facilitate in vitro studies aimed at uncovering its functional roles and interactions with other biological molecules. Understanding VWC2L's mechanisms may provide insights into its potential as a biomarker or therapeutic target in diseases such as thrombosis and atherosclerosis. Given the increasing prevalence of these conditions in the global population, ongoing research into VWC2L and its properties could pave the way for novel interventions and improvements in patient outcomes. Thus, the study of VWC2L recombinant proteins is essential in advancing our understanding of vascular biology and developing innovative strategies for disease management.
